BSE Live
Nov 13, 15:14Prev. Close
6519.30
Open Price
6530.00
Bid Price (Qty.)
6584.85 (7)
Offer Price (Qty.)
6590.45 (6)
NSE Live
Nov 13, 15:14Prev. Close
6520.00
Open Price
6525.50
Bid Price (Qty.)
6587.50 (40)
Offer Price (Qty.)
6588.00 (8)
| Cash Flow of Divis Laboratories (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 385.33 | 448.23 | 377.50 | 219.24 | 105.68 | |
| Net CashFlow From Operating Activities | 369.35 | 301.15 | 292.47 | 181.95 | 48.80 | |
| Net Cash Used In Investing Activities | -317.18 | -217.43 | -225.36 | -149.89 | -110.83 | |
| Net Cash Used From Financing Activities | -47.60 | -82.31 | -65.09 | -34.50 | 68.07 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 4.57 | 1.41 | 2.03 | -2.44 | 6.04 | |
| Cash And Cash Equivalents Begin of Year | 8.82 | 7.41 | 5.39 | 7.83 | 1.79 | |
| Cash And Cash Equivalents End Of Year | 13.39 | 8.82 | 7.41 | 5.39 | 7.83 |
12.11.2025
Neutral Divis Laboratories; target of Rs 6925: Motilal Oswal
12.11.2025
Divis Labs Standalone September 2025 Net Sales at Rs 2,660.00 crore, up 15.55% Y-o-Y
11.11.2025
Accumulate Divis Laboratories; target of Rs 7050: Prabhudas Lilladher
10.11.2025
Sell Divis Laboratories; target of Rs 5400: ICICI Securities
24.05.2024
Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix
04.11.2023
Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix
14.08.2023
Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery
19.05.2023
Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill